May 10, 2025
See all results
Balancing the Risks and Benefits of Medications
Newsletter
DONATE
ABOUT
About MedShadow
Our Team
Foundation Board
Health and Medical Advisory Panel
Podcast
MedShadow In The News
ARTICLES
The PPI Debate: Could Common Heartburn Drugs Be Harming Your Brain?
Controlled Drug Classifications: Schedule I, II, III, IV, V
FDA SIDE EFFECTS UPDATE: Baqsimi and Serious Hypersensitivity Reactions, Plus More
Are Melatonin Supplements Safe for Kids?
New Articles
Health Topics
Conditions
Medications
Wellness
Culture Desk
VIDEOS
VIDEOS
The PPI Debate: Could Common Heartburn Drugs Be Harming Your Brain?
Controlled Drug Classifications: Schedule I, II, III, IV, V
FDA SIDE EFFECTS UPDATE: Baqsimi and Serious Hypersensitivity Reactions, Plus More
Are Melatonin Supplements Safe for Kids?
FDA SIDE EFFECTS UPDATE: Migraine Drugs and High Blood Pressure, Circulation Problems
Medical Animation Videos
Patient Story Videos
Nutrition Videos
PODCAST
PODCAST
Preventable Illnesses: Lifestyle Choices Over Medication
Childhood Asthma and Obesity: The Road to Resilience
Food As Fuel: Managing Sugar Cravings to Fight Inflammation
Creativity in Veganism, and Discovering Vegan Life Balance
Preventative Senior Fitness, Super-Agers, and Trusting Your Body
INFOGRAPHICS
Login / Signup
Search
Home
Public Health - Government & Society
FDA
A to Z
Latest
Oldest
Random
A to Z
FDA
FDA
The Increasing Influence of Big Pharma on FDA Drug Advisory Committees
Jonathan Block
FDA
The Problem With Medical Device Approvals
Suzanne B. Robotti
GERD
The Purple Pill Problem: PPIs, GERD and Serious Side Effects
Janice Leary
FDA
Time For The FDA To Get Tough On Off-Label Drug Promotion
Jonathan Block
Healthy Skeptic 2
Warning: Drug Ads May Cause Confusion
Suzanne B. Robotti
FDA
Weighing Risks and Benefits of Opana ER
Suzanne B. Robotti
FDA
What Happens When The FDA Is Addicted To The Drug Industry?
Jonathan Block
FDA
Why Isn’t the FDA Tougher on Tainted Supplements?
Jonathan Block
FDA
Why Sentinel, A FDA Drug Safety Monitoring System, Is Failing
Steven Findlay
COVID-19
Why The FDA Withdrew Emergency Use Status For Hydroxychloroquine
Jonathan Block
No More Content
Go Back To Homepage
ABOUT
About MedShadow
Our Team
Foundation Board
Health and Medical Advisory Panel
Podcast
MedShadow In The News
ARTICLES
New Articles
Health Topics
Conditions
Medications
Wellness
Culture Desk
VIDEOS
Medical Animation Videos
Patient Story Videos
Nutrition Videos
PODCAST
INFOGRAPHICS
Newsletter
DONATE
Newsletter
JOIN
Start typing to see results or hit ESC to close
FDA
side effects
depression
Opioids
cancer
See all results
Username
Password
Remember Me
Sign In
Lost password?
Create an account
Enter username or email
Cancel